| Literature DB >> 35935239 |
An Xu1, Xiang-Nan Xu2, Mi Zhang3, Chun-Lian Li2, Li Liu4, De-Yuan Fu2.
Abstract
Marine-derived microorganisms possess the unique metabolic pathways to produce structurally novel secondary metabolites with potent biological activities. In this study, bioactivity-guided isolation of the marine deep-sea-derived fungus Aspergillus flavipes DS720 led to the characterization of four indole alkaloids (compounds 1-4) and four polyketides (compounds 5-8), such as two new indoles, flavonoids A (1) and B (2) with a C-6 reversed prenylation, and a new azaphilone, flaviazaphilone A (5). Their chemical structures were unambiguously established by an extensive interpretation of spectroscopic data, such as 1D/2D NMR and HRESIMS data. The absolute configurations of the new compound 5 were solved by comparing the experimental and calculated Electronic Circular Dichroism (ECD) spectra. Since sufficient amount of flavonoids A (1) was obtained, 1 was subjected to a large-scale cytotoxic activity screening against 20 different human tumor cell lines. The results revealed that 1 showed broad-spectrum cytotoxicities against HeLa, 5637, CAL-62, PATU8988T, A-375, and A-673 cell lines, with the inhibition rates of more than 90%. This study indicated that the newly discovered indole alkaloid 1 may possess certain potential for the development of lead compounds in the future.Entities:
Keywords: Aspergillus flavipes; cytotoxic activity; indole alkaloids; marine fungus; polyketides
Year: 2022 PMID: 35935239 PMCID: PMC9355579 DOI: 10.3389/fmicb.2022.959754
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1Morphology of Aspergillus flavipes DS720 cultured on PDA medium [(A), front view; (B) reverse view]; (C) Neighbor-joining tree based on ITS and β-tubulin sequences.
Figure 2Chemical structures of the isolated compounds 1–8.
H NMR (500 MHz, δ in ppm) and C NMR Data (125 MHz, δ in ppm) for 1 and 2 (measured in DMSO-d).
|
|
|
| ||
|---|---|---|---|---|
| δH
| δC | δH
| δC | |
| 1-NH | 11.25, br s | – | 10.84, br s | – |
| 2 | 8.17, s | 138.1, CH | 7.83, d (2.1) | 131.6, CH |
| 3 | 117.8, C | 107.5, C | ||
| 4 | 7.18, d (8.5) | 120.5, CH | 7.09, s | 119.4, CH |
| 5 | 8.05, dd (8.5, 1.8) | 119.5, CH | 7.96, dd (8.4, 1.9) | 119.1, CH |
| 6 | 132.1, C | 131.7, C | ||
| 7 | 7.18, br s (overlapped) | 122.2, CH | 7.10, s | 120.9, CH |
| 8 | 134.2, C | 133.5, C | ||
| 9 | 125.2, C | 127.1, C | ||
| 10 | 9.95, s | 185.0, CH | 166.1, C | |
| 11 | 40.2, C | 40.2, C | ||
| 12 | 6.15, dd (17.5, 10.6) | 146.3, CH | 6.12, dd (17.5, 10.6) | 146.4, CH |
| 13 | 5.08, d (10.6) 4.98, d (17.5) | 112.4, CH2 | 5.07, d (10.6) 5.00, d (17.5) | 112.2, CH2 |
| 14 | 1.50, s | 27.5, CH3 | 1.48, s | 27.4, CH3 |
| 15 | 1.50, s | 27.5, CH3 | 1.48, s | 27.4, CH3 |
H NMR (500 MHz, δ in ppm) and C NMR Data (125 MHz, δ in ppm) for 5 (measured in DMSO-d).
|
| δH
| δC |
|---|---|---|
| 1 | 4.62, dd (10.6, 5.2) | 68.0, CH2 |
| 3 | 159.7, C | |
| 4 | 5.74, s | 103.4, CH |
| 4a | 150.8, C | |
| 5 | 5.68, d (1.5) | 116.7, CH |
| 6 | 195.1, C | |
| 7 | 73.8, C | |
| 8 | 5.02, d (10.0) | 75.5, CH |
| 8a | 3.18, m | 35.1, CH |
| 9 | 6.00, d (15.9) | 126.0, CH |
| 10 | 6.29, m | 133.4, CH |
| 11 | 1.79, d (7.4) | 18.6, CH3 |
| 12 | 1.10, s | 19.8, CH3 |
| 1' | 169.2, C | |
| 2' | 109.9, C | |
| 3' | 161.1, C | |
| 4' | 6.16, d (2.3) | 100.9, CH |
| 5' | 140.1, C | |
| 6' | 6.14 d (2.3) | 110.1, CH |
| 7' | 159.6, C | |
| 8' | 2.25, s | 21.8, CH3 |
Figure 3Selected Homonuclear chemical shift Correlation Spectroscopy (COSY), eteronuclear Multiple-Bond Correlation (HMBC), and Nuclear Overhauser Effect Spectroscopy (NOESY) correlations of 1, 2, and 5.
Figure 4The experimental and calculated ECD spectra of compound 5.
Figure 5Cytotoxicities of compound 1 against 20 different human tumor cell lines.